F19.281
Other psychoactive substance dependence with psychoactive substance-induced sexual dysfunction
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code F19.281 refers to a condition where an individual is dependent on unspecified psychoactive substances, and this dependence is accompanied by sexual dysfunction caused by the substance's effects. Psychoactive substances include drugs that affect the mind, mood, or behavior, such as alcohol, sedatives, stimulants, or hallucinogens. Dependence on these substances can lead to a variety of health complications, including impacts on sexual health. Recognizing the signs and understanding the nature of this condition can help in seeking appropriate care and support.
Causes & Symptoms
Clinical Causes: Chronic use of psychoactive substances leading to dependence Repeated exposure to substances that alter neurotransmitter activity related to sexual function Underlying mental health issues co-occurring with substance dependence Social and environmental factors that promote substance use
Key Symptoms: Decreased sexual desire or libido Erectile dysfunction in men Difficulty achieving or maintaining arousal Problems with orgasm or ejaculation Reduced sexual satisfaction Emotional or physical withdrawal symptoms when not using the substance Changes in sexual behavior or preferences
Diagnostic & Treatment
Diagnosis Path: Diagnosis of F19.281 involves a comprehensive assessment including medical history, physical examination, and psychological evaluation. Healthcare providers may look for signs of psychoactive substance dependence, such as withdrawal symptoms or increased tolerance. They also assess sexual function and any changes correlated with substance use. Laboratory tests or screenings for substances might be conducted to confirm dependency. Diagnostic criteria from the DSM-5 or other standardized guidelines support identifying substance dependence and related sexual dysfunctions.
Treatment Protocols: Treatment approaches typically focus on addressing both substance dependence and sexual dysfunction. Interventions may include: - **Detoxification and abstinence** from the offending substance under medical supervision - **Psychotherapy**, such as cognitive-behavioral therapy (CBT), to modify behaviors and address underlying mental health issues - **Medication-assisted treatment** (MAT) when appropriate, to manage dependence or specific symptoms - **Couples therapy or sexual therapy** to improve intimacy and sexual functioning - **Support groups or peer support** for ongoing recovery Addressing sexual dysfunction often involves counseling, education, and sometimes medication to help restore healthy sexual response once substance use is managed. Coordinated care from healthcare professionals specializing in addiction, mental health, and sexual health can improve outcomes.
Clinical Advice & FAQs
Billing Guidance
Is F19.281 a billable ICD-10 code?
Yes, F19.281 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F19.281?
Clinical documentation must specify the nature of Other psychoactive substance dependence with psychoactive substance-induced sexual dysfunction and any associated comorbidities for accurate reporting.
Cite this Clinical Reference